Ocrelizumab for the treatment of multiple sclerosis

K Bigaut, J De Seze, N Collongues - Expert Review of …, 2019 - Taylor & Francis
Introduction: In the past decade, the role of B cells in the pathogenesis of multiple sclerosis
(MS) is coming to the forefront. Depletion of B cells by anti-CD20 monoclonal antibodies …
被引用次数：34 相关文章

Ocrelizumab for the treatment of multiple sclerosis

K Bigaut, J De Seze… - Expert review of …, 2019 - pubmed.ncbi.nlm.nih.gov
In the past decade, the role of B cells in the pathogenesis of multiple sclerosis (MS) is
coming to the forefront. Depletion of B cells by anti-CD20 monoclonal antibodies (mAbs) has …

Ocrelizumab for the treatment of multiple sclerosis.

K Bigaut, J De Seze, N Collongues - Expert Review of …, 2018 - europepmc.org
INTRODUCTION: In the past decade, the role of B cells in the pathogenesis of multiple
sclerosis (MS) is coming to the forefront. Depletion of B cells by anti-CD20 monoclonal …

[引用][C] Ocrelizumab for the treatment of multiple sclerosis

K Bigaut, J de Seze, N Collongues - Expert Review of …, 2018 - hal.science
Ocrelizumab for the treatment of multiple sclerosis - Archive ouverte HAL Accéder
directement au contenu Documentation FR Français (FR) Anglais (EN) Se connecter HAL …